| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 08/30/2007 | WO2007098169A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | WO2007098010A2 Improved low molecular weight myc-max inhibitors |
| 08/30/2007 | WO2007097937A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007097276A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007096315A1 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors |
| 08/30/2007 | WO2007095812A1 Substituted [1,3,5] triazine compounds, their processes for preparation and uses thereof |
| 08/30/2007 | WO2007079163A3 Prokineticin 1 receptor antagonists |
| 08/30/2007 | WO2007071455B1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 08/30/2007 | WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 08/30/2007 | WO2007064566A3 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 08/30/2007 | WO2007042912A3 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 08/30/2007 | WO2006127503A3 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| 08/30/2007 | WO2006015854A3 Azetidine derivatives as ccr-3 receptor antagonists |
| 08/30/2007 | WO2005063734A3 Substituted thiophenes |
| 08/30/2007 | US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203210 Thiazolyl-benzimidazoles |
| 08/30/2007 | US20070203209 Useful indole compounds |
| 08/30/2007 | US20070203201 Substituted anthranilamides for controlling invertebrate pests |
| 08/30/2007 | US20070203200 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical |
| 08/30/2007 | US20070203199 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| 08/30/2007 | US20070203194 Calcium channel modulators comprising 3-thio-4H-1,2,4-triazoles or S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 08/30/2007 | US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 08/30/2007 | US20070203192 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety |
| 08/30/2007 | US20070203189 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases |
| 08/30/2007 | US20070203188 Low molecular weight Myc-Max inhibitors |
| 08/30/2007 | US20070203187 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 08/30/2007 | US20070203179 Azadecalin Glucocorticoid Receptor Modulators |
| 08/30/2007 | US20070203155 Compounds And Compositions As Ppar Modulators |
| 08/30/2007 | US20070203153 Compositions and methods for treating thrombocytopenia |
| 08/30/2007 | US20070203148 Haloalkyl Carboxamides |
| 08/30/2007 | US20070203147 2-Aminothiazole Compounds Useful As Aspartyl Protease Inhibitors |
| 08/30/2007 | US20070203130 sodium channel and calcium channel inhibitors, such as 2-Indol-1-yl-N-[5-(thiazol-2-ylsulfamoyl)-naphthalen-1-yl]-propionamide, used as analgesics or for the treatment of neurodegenerative disorders, anxiety, depression, arrhythmia, ataxia, multiple sclerosis, irritable bowel syndrome or incontinence |
| 08/30/2007 | US20070203129 2-Pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use |
| 08/30/2007 | US20070203128 Modulation of Pathogenicity |
| 08/30/2007 | US20070203121 Substituted indole compounds, their preparation and use in medicaments |
| 08/30/2007 | US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 08/30/2007 | US20070203072 Hcv Ns-3 Serine Protease Inhibitors |
| 08/30/2007 | CA2643963A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | CA2643272A1 Gent for treating or preventing digestive ulcer |
| 08/30/2007 | CA2642921A1 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors |
| 08/30/2007 | CA2642762A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | CA2642619A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | CA2642610A1 Amide derivative or salt thereof |
| 08/30/2007 | CA2642229A1 Compositions and methods for inhibition of the jak pathway |
| 08/30/2007 | CA2637531A1 Compounds having 5-ht6 receptor affinity |
| 08/29/2007 | EP1826208A1 Cyanine compound, optical recording material utilizing the compound, and optical recording medium |
| 08/29/2007 | EP1824847A2 Pyridazinone compounds |
| 08/29/2007 | EP1824846A2 Novel compounds for the treatment of neurological disorders |
| 08/29/2007 | EP1824843A2 Inhibitors of protein kinases |
| 08/29/2007 | EP1824834A1 Meta-substituted thiazolidinones, the production thereof and their use as medicaments |
| 08/29/2007 | EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 08/29/2007 | EP1590344A4 Anti-cancer medicaments |
| 08/29/2007 | EP1517899B1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | CN101027560A Human G protein-coupled receptor for the treatment of hyperglycemia and related disorders and its modulator |
| 08/29/2007 | CN101027299A Carbo- and hetero-cyclic antibiotics and use thereof |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/29/2007 | CN100334083C Piperidine derivatives as CCR5 inhibitors |
| 08/29/2007 | CN100334077C Benzimidazole derivatives and their use as GNRH antagonists |
| 08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
| 08/28/2007 | US7262293 precipitating from acidic aqueous solutions dropped into an aqueous or anhydrous solvents, then freeze drying to form amorphous salts having storage stability; monocyclic beta-lactam antibiotics |
| 08/28/2007 | US7262207 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 08/28/2007 | US7262204 Modulation of CCR4 function |
| 08/28/2007 | US7262198 Substituted heterocyclic compounds |
| 08/28/2007 | US7262196 Tri(cyclo) substituted amide glucokinase activator compounds |
| 08/28/2007 | US7262191 Benzothiadiazine compounds |
| 08/28/2007 | US7262185 For therapy and prophylaxis of infectious diseases of HIV, in particular, AIDS and is also suitable for oral administration |
| 08/28/2007 | US7262183 Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases |
| 08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 08/23/2007 | WO2007095588A1 Pi-3 kinase inhibitors and methods of their use |
| 08/23/2007 | WO2007095124A2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 08/23/2007 | WO2007094513A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 08/23/2007 | WO2007093870A2 A process for the preparation of risperidone |
| 08/23/2007 | WO2007093542A1 Pyridine-2-carboxamide derivatives |
| 08/23/2007 | WO2007093541A1 Heterocyclic antiviral compounds |
| 08/23/2007 | WO2007093540A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators |
| 08/23/2007 | WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 08/23/2007 | WO2007093402A1 Pesticides containing a bicyclic bisamide structure |
| 08/23/2007 | WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | WO2007077574A3 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS |
| 08/23/2007 | WO2007071396A3 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 08/23/2007 | WO2007068473A3 Organic compounds |
| 08/23/2007 | WO2007061741A3 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 08/23/2007 | WO2007059257A3 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 08/23/2007 | US20070197782 N4-[2,2-Dimethyl-3-oxo-benzo[1,4]thiazin-6-yl]-5-fluoro-N2-(3-hydroxy-4,5-dimethoxyphenyl)-2,4-pyrimidinediamine;5-Fluoro-N2-(3-hydroxy-4,5-dimethoxyphenyl)-N4-[3-oxo-benzo[1,4]thiazin-6-yl]-2,4-pyrimidinediamine; autoimmune diseases |
| 08/23/2007 | US20070197619 Ion Channel Modulators |
| 08/23/2007 | US20070197611 Fermentative preparation process for and crystal forms of cytostatics |
| 08/23/2007 | US20070197610 Benzisoxazoles |
| 08/23/2007 | US20070197609 Salts of inducible nitric oxide synthase dimerization inhibitors |
| 08/23/2007 | US20070197598 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/23/2007 | US20070197587 Quinoline Derivatives as CRTH2 Antagonists |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |